Latest receivables for 7630.HK: $5.6M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), 7630.HK shows a receivables of $5.6M. That compares with $91K in the prior-year period — up 6039.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 7630.HK's receivables is now $5.6M (was $91K) — a 6039.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Impact Therap-b is outperforming or lagging.
Tracking 7630.HK's receivables over time shows whether Impact Therap-b is scaling, shrinking, or reshaping that part of the business. The current reading is $5.6M That compares with $91K in the prior-year period — up 6039.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Impact Therap-b's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $5.6M) with ownership activity and broader fundamentals.